European Stable Isotopes for Nuclear Medicine
Funds industrial production of stable isotopes needed for radionuclide therapies and a more resilient European medical supply chain.
Targeted radionuclide therapies depend on stable isotopes that Europe often obtains from outside the EU. Limited supply creates a strategic bottleneck for scaling new cancer treatments and other nuclear-medicine applications.
Projects must develop and optimise EU-based production of stable isotopes used to manufacture therapeutic radionuclides. The work should bring together nuclear science, phys…
Projects must develop and optimise EU-based production of stable isotopes used to manufacture therapeutic radionuclides. The work should bring together nuclear science, physics, engineering and industrial production, covering source-material access, process development and routes to reliable scale.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up